AUG 22, 2020 9:21 AM PDT

Could a Drug for Bipolar Disorder Treat COVID-19?

WRITTEN BY: Annie Lennon

Researchers have found that a drug currently used to treat bipolar disorder and hearing loss may also treat COVID-19 thanks to itsantibacterial and anti-inflammatory properties. 

Known as Ebselen, the new findings come after previous research showing it is able to block enzymes known as ‘Mpro’ that are necessary for the coronavirus to replicate in healthy cells. 

For the most recent study, researchers from the University of Chicago created computer models to understand how the drug and Mpro interact. In the end, they found that Ebelsen is able to bind to two different sites on the enzyme- both key for its function and ability to replicate. 

These findings suggest that Ebelsen may be a good drug candidate to treat COVID-19- especially as it is already in use, demonstrating its safety. The researchers also say that the drug highlights another vulnerability of the coronavirus that scientists may want to continue to investigate as the search for other drug candidates persist. 

Although promising results, however, the researchers also say that a lot more research is needed before they can properly determine how effective the drug may be at treating COVID-19. While computer models show it may be effective, real-life trials outside of the lab are needed to confirm its effectiveness. 

As such, while research may advance on this drug candidate, the researchers plan to focus their research on finding ore of SARS-CoV-2’s weak spots. 

“The main protease is one of many proteins in the virus that could be targeted with existing, repurposed drugs, and there are thousands of compounds to be considered,” says Professor Juan de Pablo, one of the study’s authors. 

“We are systematically investigating each of the proteins involved in the virus function and investigating their vulnerabilities and their responses to a wide range of drugs.”

 

Sources: Science AdvancesMedical News Today

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
AUG 22, 2020
Drug Discovery & Development
Honey More Effective than Medication to Treat Cough
AUG 22, 2020
Honey More Effective than Medication to Treat Cough
Upper respiratory tract infections are the most common reason for doctors to prescribe antibiotics. However, as most of ...
AUG 25, 2020
Cannabis Sciences
FDA Approves Cannabis Drug to Treat Rare Genetic Disease
AUG 25, 2020
FDA Approves Cannabis Drug to Treat Rare Genetic Disease
The US Food and Drug Administration has approved Epidiolex, a cannabidiol (CBD) oral solution, to treat seizures linked ...
SEP 07, 2020
Drug Discovery & Development
Improving Antirejection Medications in Heart Transplant
SEP 07, 2020
Improving Antirejection Medications in Heart Transplant
Placing patients on anti-rejection drugs is reality for all heart transplant patients. As such, recent research at Johns ...
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
SEP 21, 2020
Drug Discovery & Development
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
SEP 21, 2020
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
The World Health Organization has endorsed a protocol to put African herbal medicines through clinical trials as possibl ...
OCT 23, 2020
Drug Discovery & Development
Common Asthmatic Treatments Increase Risk of Bone Fractures
OCT 23, 2020
Common Asthmatic Treatments Increase Risk of Bone Fractures
A study published in the journal Thorax found that taking steroid inhalers or tablets for asthma treatment to control fl ...
Loading Comments...